TRPV1 activity reduces lipid storage, which is a promising therapeutic tool for atherosclerosis, as the use of copper sulfide (CuS) nanoparticles targeting TRPV1 channels in vascular smooth muscle cells helps to attenuate fat accumulation (Gao et al., 2018). The gene discussed is TRPV1; the disease is atherosclerosis.